subject: UMLS:C0279328

subject_name: Hyperbaric Oxygen (substance)

object_name: Myocardial Reperfusion Injury


subject: UMLS:C0879331

subject_name: BCR-ABL Peptide Vaccine

object_name: leukemia

tested_intervention: yes


subject: UMLS:C0879331

object_name: childhood leukemia


subject: CHEBI:63724

object_name: Mesothelioma

tested_intervention: unsure


subject: CHEBI:63724

object_name: mesothelial neoplasm


subject: CHEBI:63724

object_name: malignant mesothelioma


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: Healthcare associated pneumonia


subject: CHEBI:17650

object_name: ventilator-associated pneumonia


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: thalassemia


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: hereditary hemorrhagic telangiectasia


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: PUBCHEM.COMPOUND:4240

subject_name: Mometasone furoate

object_name: perennial allergic rhinitis


subject: CHEBI:6970

subject_name: Mometasone


subject: CHEBI:91408

subject_name: Fedratinib

object_name: chronic neutrophilic leukemia


subject: CHEBI:91408

object_name: myeloproliferative neoplasm


subject: CHEBI:91408

object_name: Malignant myeloproliferative neoplasm


subject: CHEBI:91408

object_name: Myelodysplasia


subject: CHEBI:91408

object_name: Miller-Dieker lissencephaly syndrome


subject: CHEBI:91408

object_name: myoclonic dystonia 11


subject: UMLS:C5446586

subject_name: P2RX3 Antagonist BAY 1817080

object_name: Urinary Urgency


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: papillary renal cell carcinoma


subject: UMLS:C3641122


subject: CHEBI:231369

subject_name: Savolitinib


subject: UMLS:C1831929

object_name: Childhood Breast Carcinoma


subject: UMLS:C1831929

object_name: breast carcinoma


subject: UMLS:C1831929

object_name: breast cancer


subject: PUBCHEM.COMPOUND:168009928

subject_name: Keyhole limpet hemocyanin

object_name: adult germ cell tumor


subject: PUBCHEM.COMPOUND:168009928

object_name: germ cell tumor


subject: PUBCHEM.COMPOUND:168009928

object_name: childhood germ cell tumor


subject: PUBCHEM.COMPOUND:168009928

object_name: Germ Cell Cancer


subject: PUBCHEM.COMPOUND:168009928

object_name: leukemia


subject: PUBCHEM.COMPOUND:168009928

object_name: childhood leukemia


subject: UNII:FV4Y0JO2CX

subject_name: keyhole-limpet hemocyanin


subject: UNII:FV4Y0JO2CX


subject: UNII:FV4Y0JO2CX


subject: UNII:FV4Y0JO2CX


subject: UNII:FV4Y0JO2CX


subject: UNII:FV4Y0JO2CX


subject: CHEMBL.COMPOUND:CHEMBL5314988

subject_name: KEYHOLE LIMPET HEMOCYANIN


subject: CHEMBL.COMPOUND:CHEMBL5314988


subject: CHEMBL.COMPOUND:CHEMBL5314988


subject: CHEMBL.COMPOUND:CHEMBL5314988


subject: CHEMBL.COMPOUND:CHEMBL5314988


subject: CHEMBL.COMPOUND:CHEMBL5314988


subject: UMLS:C0064332


subject: UMLS:C0064332


subject: UMLS:C0064332


subject: UMLS:C0064332


subject: UMLS:C0064332


subject: UMLS:C0064332


subject: CHEMBL.COMPOUND:CHEMBL2108875

subject_name: TETANUS TOXOID


subject: CHEMBL.COMPOUND:CHEMBL2108875


subject: CHEMBL.COMPOUND:CHEMBL2108875


subject: CHEMBL.COMPOUND:CHEMBL2108875


subject: CHEMBL.COMPOUND:CHEMBL2108875


subject: CHEMBL.COMPOUND:CHEMBL2108875


subject: CHEMBL.COMPOUND:CHEMBL2108875

object_name: adult lymphoma


subject: CHEMBL.COMPOUND:CHEMBL2108875

object_name: lymphoma


subject: CHEMBL.COMPOUND:CHEMBL2108875

object_name: pediatric lymphoma


subject: UMLS:C0305062

subject_name: Tetanus Toxoid


subject: UMLS:C0305062


subject: UMLS:C0305062


subject: UMLS:C0305062


subject: UMLS:C0305062


subject: UMLS:C0305062


subject: UMLS:C0305062


subject: UMLS:C0305062


subject: UMLS:C0305062


subject: UMLS:C0039620

subject_name: Tetanus Vaccine


subject: UMLS:C0039620


subject: UMLS:C0039620


subject: UMLS:C0039620


subject: UMLS:C0039620


subject: UMLS:C0039620


subject: UMLS:C0039620


subject: UMLS:C0039620


subject: UMLS:C0039620


subject: UNII:345354O7AT

object_name: type 2 diabetes mellitus


subject: UNII:90Z2UF0E52

subject_name: Mepolizumab

object_name: asthma


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Stress Fracture


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Cognitive impairment


subject: CHEBI:89324

object_name: digestive system neoplasm


subject: CHEBI:89324

object_name: Neoplasm of the gastrointestinal tract


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: cardio-renal syndrome


subject: UNII:DB1041CXDG

subject_name: BELANTAMAB

object_name: plasma cell myeloma


subject: UNII:DB1041CXDG

object_name: corneal disease


subject: UNII:DB1041CXDG

object_name: blood protein disease


subject: UNII:DB1041CXDG

object_name: Paraproteinemia


subject: UNII:DB1041CXDG

object_name: hematologic disorder


subject: UNII:DB1041CXDG

object_name: plasma cell neoplasm


subject: UNII:DB1041CXDG

object_name: neoplasm


subject: UMLS:C3826989


subject: UMLS:C3826989


subject: UMLS:C3826989


subject: UMLS:C3826989


subject: UMLS:C3826989


subject: UMLS:C3826989


subject: UMLS:C3826989


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:63791

subject_name: Lenalidomide


subject: CHEBI:63791


subject: CHEBI:63791


subject: CHEBI:63791


subject: CHEBI:63791


subject: PUBCHEM.COMPOUND:11670360

subject_name: Nirogacestat


subject: PUBCHEM.COMPOUND:11670360


subject: PUBCHEM.COMPOUND:11670360


subject: PUBCHEM.COMPOUND:11670360


subject: PUBCHEM.COMPOUND:11670360


subject: PUBCHEM.COMPOUND:11670360


subject: PUBCHEM.COMPOUND:11670360


subject: CHEBI:4672

subject_name: Docetaxel

object_name: squamous cell carcinoma


subject: CHEBI:35854

subject_name: Valaciclovir

object_name: viral disease


subject: UMLS:C5446640

subject_name: Technetium Tc-99m Anti-HER2 Affibody HPArk2

object_name: Childhood Breast Carcinoma


subject: UMLS:C5446640

object_name: breast carcinoma


subject: UMLS:C5446640

object_name: breast cancer


subject: UMLS:C4045537


subject: UNII:0282IF4JC8

subject_name: Siremadlin

object_name: acute myeloid leukemia by FAB classification


subject: UNII:0282IF4JC8

object_name: acute myeloid leukemia


subject: UMLS:C0085219

subject_name: HIV Core Protein p24

object_name: HIV Seronegativity


subject: UMLS:C0085219

object_name: HIV infection


subject: GTOPDB:12347

subject_name: penpulimab

object_name: Disseminated Malignant Neoplasm


subject: GTOPDB:12347

object_name: Embolism, Tumor


subject: GTOPDB:12347

object_name: Neoplasm Metastasis


subject: GTOPDB:12347

object_name: head and neck neoplasm


subject: GTOPDB:12347

object_name: Recurrent disease


subject: CHEMBL.COMPOUND:CHEMBL4297571

subject_name: PENPULIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297571


subject: CHEMBL.COMPOUND:CHEMBL4297571


subject: CHEMBL.COMPOUND:CHEMBL4297571


subject: CHEMBL.COMPOUND:CHEMBL4297571


subject: UMLS:C4723695


subject: UMLS:C4723695


subject: UMLS:C4723695


subject: UMLS:C4723695


subject: UMLS:C4723695


subject: UMLS:C2981359

subject_name: fezakinumab

object_name: rheumatoid arthritis


subject: CHEBI:47657

subject_name: Roflumilast

object_name: schizophrenia


subject: CHEBI:4806

subject_name: Epigallocatechin gallate

object_name: Lesion of cervix


subject: CHEBI:4806

object_name: papilloma


subject: CHEBI:27470

subject_name: Folic acid


subject: CHEBI:27470


subject: CHEBI:28911

subject_name: cob(III)alamin


subject: CHEBI:28911


subject: PUBCHEM.COMPOUND:165339223

subject_name: Vitamin B 12


subject: PUBCHEM.COMPOUND:165339223


subject: HMDB:HMDB0000607

subject_name: Cyanocobalamin


subject: HMDB:HMDB0000607


subject: CHEBI:176843

subject_name: vitamin B12


subject: CHEBI:176843


subject: UMLS:C0086024

subject_name: cobalamins


subject: UMLS:C0086024


subject: CHEBI:17439


subject: CHEBI:17439


subject: UMLS:C2936883

subject_name: Vitamin B12 [EPC]


subject: UMLS:C2936883


subject: GTOPDB:8002

subject_name: bavituximab

object_name: non-small cell lung carcinoma


subject: UNII:Q16CT95N25


subject: UMLS:C1707382


subject: PUBCHEM.COMPOUND:9819685

subject_name: Etamicastat

object_name: heart failure


subject: PUBCHEM.COMPOUND:9819685

object_name: congestive heart failure


subject: PUBCHEM.COMPOUND:9819685

object_name: hypertension


subject: PUBCHEM.COMPOUND:9819685

object_name: Hypertension, CTCAE


subject: UMLS:C2350964


subject: UMLS:C2350964


subject: UMLS:C2350964


subject: UMLS:C2350964


subject: CHEMBL.COMPOUND:CHEMBL2109205

subject_name: nonacog alfa

object_name: hemophilia B leyden


subject: CHEBI:4670

subject_name: Dobutamine

object_name: acute myocardial infarction


subject: CHEBI:4670

object_name: Acute Myocardial Infarction by ECG Finding


subject: CHEBI:4670

object_name: cardiogenic shock


subject: UNII:I031V2H011

subject_name: Tocilizumab


subject: UNII:I031V2H011


subject: UNII:I031V2H011


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: Refractory acute myeloid leukemia


subject: PUBCHEM.COMPOUND:596

object_name: Refractory Mixed Phenotype Acute Leukemia


subject: PUBCHEM.COMPOUND:596

object_name: Refractory Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:596

object_name: Recurrent Mixed Phenotype Acute Leukemia


subject: PUBCHEM.COMPOUND:596

object_name: Recurrent Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:596

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: PUBCHEM.COMPOUND:596

object_name: Recurrent Acute Myeloid Leukemia


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596

object_name: Treatment related acute myeloid leukaemia


subject: PUBCHEM.COMPOUND:596

object_name: myeloid leukemia associated with down syndrome


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: UNII:PE952ANF83

subject_name: Uproleselan


subject: UNII:PE952ANF83


subject: UNII:PE952ANF83


subject: UNII:PE952ANF83


subject: UNII:PE952ANF83


subject: UNII:PE952ANF83


subject: UNII:PE952ANF83


subject: UNII:PE952ANF83


subject: UNII:PE952ANF83


subject: UNII:PE952ANF83


subject: UMLS:C4082808

subject_name: Advagraf

object_name: nephrotic syndrome


subject: UMLS:C4082808

object_name: Nephrotic Syndrome, CTCAE


subject: UNII:XX2MN88N5D

subject_name: Efalizumab

object_name: Chronic small plaque psoriasis


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: Microvascular coronary artery disease


subject: UNII:PH2Q4E64WM

subject_name: LACTIPLANTIBACILLUS PLANTARUM 299V

object_name: Pregnant


subject: DRUGBANK:DB10640

subject_name: Beet

object_name: cardiovascular disorder


subject: UMLS:C3491843

object_name: Rett syndrome


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: Advanced Melanoma


subject: UMLS:C4053601


subject: UNII:OX5LRQ5H6K

subject_name: FIANLIMAB


subject: UMLS:C4329332

subject_name: Fianlimab


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Stomach cancer


subject: CHEBI:74705

object_name: gastric cancer


subject: CHEBI:74705

object_name: microinvasive gastric cancer


subject: CHEBI:74705

object_name: Sentinel node (disorder)


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: MESH:D011849

subject_name: Radioactive Tracers


subject: MESH:D011849


subject: MESH:D011849


subject: MESH:D011849


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: migraine with or without aura, susceptibility to, 1


subject: PUBCHEM.COMPOUND:444033

subject_name: Ciclesonide

object_name: perennial allergic rhinitis


subject: UMLS:C0742246

subject_name: CHEMOTHERAPY CIS PLATIN

object_name: intrahepatic cholangiocarcinoma


subject: UMLS:C0742246

object_name: Effects of chemotherapy


subject: PR:000014196

subject_name: eukaryotic-type large ribosomal subunit protein uL22


subject: PR:000001919

subject_name: programmed cell death protein 1


subject: UMLS:C0772037

subject_name: ROSE HIPS

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C0772037

object_name: obesity


subject: UMLS:C0772037

object_name: Obesity, CTCAE


subject: UMLS:C3641087

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C3641087

object_name: non-Hodgkin lymphoma


subject: UMLS:C3641087

object_name: Adult Non-Hodgkin Lymphoma


subject: UMLS:C3641087

object_name: Childhood Non-Hodgkin Lymphoma


subject: UMLS:C3641087

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:9150

subject_name: Simvastatin

object_name: lung cancer


subject: CHEBI:9150

object_name: lung neoplasm


subject: CHEBI:9150

object_name: lung carcinoma


subject: UMLS:C4688355

subject_name: Mezagitamab

object_name: myasthenia gravis


subject: UMLS:C4688355

object_name: Myasthenia Gravis, CTCAE


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Renal Failure, CTCAE


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3367

object_name: acute lymphoblastic leukemia


subject: CHEBI:31348

subject_name: Capecitabine

object_name: small intestine adenocarcinoma


subject: CHEBI:31348

object_name: Small intestine carcinoma recurrent


subject: CHEBI:90881

subject_name: Camptosar


subject: CHEBI:90881


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: CHEBI:50634

object_name: sleep apnea


subject: CHEBI:50634

object_name: Sleep Apnea, CTCAE


subject: CHEBI:27690

subject_name: Acetazolamide


subject: CHEBI:27690


subject: CHEBI:5062

subject_name: Finasteride


subject: CHEBI:5062


subject: CHEBI:49956

subject_name: Xenon

object_name: obstructive sleep apnea syndrome


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam

object_name: Lower extremity problem


subject: PUBCHEM.COMPOUND:9824461

object_name: urinary system disorder


subject: PUBCHEM.COMPOUND:9824461

object_name: female reproductive system disorder


subject: UMLS:C3274703

object_name: glioblastoma


subject: UMLS:C3274703

object_name: Childhood Glioblastoma


subject: UMLS:C3274703

object_name: adult glioblastoma


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: diastolic heart failure


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:31348

object_name: gastric adenocarcinoma


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Metastatic Colorectal Carcinoma


subject: UNII:52CMI0WC3Y

object_name: Refractory Colorectal Carcinoma


subject: UNII:52CMI0WC3Y

object_name: Stage IV Colorectal Cancer AJCC v7


subject: UNII:52CMI0WC3Y

object_name: Stage IVB Colorectal Cancer AJCC v7


subject: UNII:52CMI0WC3Y

object_name: Stage IVA Colorectal Cancer AJCC v7


subject: UNII:52CMI0WC3Y

object_name: Colorectal cancer recurrent


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: CHEBI:30314

subject_name: Lipoic acid

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:30314

object_name: obesity


subject: CHEBI:30314

object_name: Obesity, CTCAE


subject: CHEBI:30314

object_name: Abdominal obesity


subject: CHEBI:30314

object_name: Obesity, Visceral


subject: CHEBI:30314

object_name: Females


subject: CHEBI:43796

subject_name: (S)-lipoic acid


subject: CHEBI:43796


subject: CHEBI:43796


subject: CHEBI:43796


subject: CHEBI:43796


subject: CHEBI:43796


subject: CHEBI:16494

subject_name: thioctic acid


subject: CHEBI:16494


subject: CHEBI:16494


subject: CHEBI:16494


subject: CHEBI:16494


subject: CHEBI:16494


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: dry eye syndrome


subject: CHEBI:134738

subject_name: Laquinimod

object_name: Multiple sclerosis relapse


subject: UMLS:C0003451

subject_name: Antiviral Agents

object_name: inherited hemoglobinopathy


subject: UMLS:C0003451

object_name: hemoglobinopathy


subject: UMLS:C0003451

object_name: chronic hepatitis C virus infection


subject: CHEBI:135918

subject_name: Tucidinostat

object_name: pediatric osteosarcoma


subject: CHEBI:135918

object_name: Osteosarcoma


subject: UNII:5S371K6132

subject_name: Rivoceranib


subject: UNII:5S371K6132


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Rash and Dermatitis Associated with Chemoradiation, CTCAE


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: CHEBI:233309

subject_name: Adagrasib

object_name: Advanced cancer


subject: CHEBI:233309

object_name: Adult Solid Neoplasm


subject: CHEBI:233309

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:233309

object_name: Embolism, Tumor


subject: CHEBI:233309

object_name: Neoplasm Metastasis


subject: CHEBI:233309

object_name: cancer


subject: UMLS:C2347328

subject_name: sirolimus protein-bound particles

object_name: non-small cell lung carcinoma


subject: UMLS:C2347328


subject: UMLS:C2347328


subject: UMLS:C2347328


subject: UMLS:C2347328


subject: UMLS:C2347328


subject: UMLS:C2347328


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: Non-Severe Aplastic Anemia


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:91083

subject_name: Romiplostim


subject: UMLS:C1505595


subject: MESH:C000722747

subject_name: mRNA-1010 influenza vaccine

object_name: respiratory syncytial virus infectious disease


subject: MESH:C000722747

object_name: cytomegalovirus infection


subject: MESH:C000722747


subject: MESH:D000090983

subject_name: 2019-nCoV Vaccine mRNA-1273


subject: MESH:D000090983


subject: MESH:D000090983


subject: DRUGBANK:DB18739


subject: DRUGBANK:DB18739


subject: DRUGBANK:DB18739


subject: MESH:C000722750

subject_name: mRNA-1647 cytomegalovirus vaccine


subject: MESH:C000722750


subject: MESH:C000722750


subject: CHEBI:4856

subject_name: Esmolol

object_name: brain aneurysm


subject: CHEBI:4856

object_name: cerebral arterial disease


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:44915


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:9130


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: neuromyelitis optica


subject: CHEBI:4026

object_name: chronic inflammatory demyelinating polyradiculoneuropathy


subject: CHEBI:4026

object_name: autoimmune encephalitis


subject: CHEBI:4026

object_name: multiple sclerosis


subject: CHEBI:4026

object_name: myelin oligodendrocyte glycoprotein antibody-associated disease


subject: CHEBI:4026

object_name: autoimmune disorder of the nervous system


subject: CHEBI:4026

object_name: POEMS syndrome


subject: CHEBI:4026

object_name: Autoimmunity


subject: CHEBI:4026

object_name: acquired idiopathic inflammatory myopathy


subject: CHEBI:4026

object_name: idiopathic inflammatory myopathy


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367

object_name: myasthenia gravis


subject: PUBCHEM.COMPOUND:3367

object_name: Myasthenia Gravis, CTCAE


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: UMLS:C1618891

subject_name: Injection, azacitidine, 1 mg administered

object_name: precursor B-cell acute lymphoblastic leukemia


subject: UMLS:C1618891

object_name: B-cell childhood acute lymphoblastic leukemia


subject: UMLS:C1618891

object_name: B-cell adult acute lymphocytic leukemia


subject: UMLS:C1618891

object_name: B-cell acute lymphoblastic leukemia


subject: UMLS:C1618891

object_name: High Risk Acute Lymphoblastic Leukemia


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:61397

subject_name: Neratinib

object_name: Unresectable Malignant Solid Neoplasm


subject: CHEBI:61397

object_name: Metastatic Malignant Solid Neoplasm


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: CHEBI:41977

subject_name: Daunorubicin

object_name: acute myeloid leukemia


subject: UMLS:C3253066

subject_name: WIN 34B

object_name: osteoarthritis, knee


subject: UMLS:C2347437

subject_name: PVA Microporous Hydrospheres

object_name: pancreatic neuroendocrine neoplasm


subject: UMLS:C2347437

object_name: pancreatic neuroendocrine tumor


subject: UMLS:C2347437

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C2347437

object_name: Embolism, Tumor


subject: UMLS:C2347437

object_name: Neoplasm Metastasis


subject: UMLS:C2347437

object_name: Gastrointestinal Carcinoid Tumor


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:90001

subject_name: cystathionine ketimine

object_name: plasma cell myeloma


subject: CHEBI:90001

object_name: smoldering plasma cell myeloma


subject: CHEBI:90001

object_name: monoclonal gammopathy of uncertain significance


subject: CHEBI:28082


subject: CHEBI:28082


subject: CHEBI:28082


subject: UMLS:C3813556

subject_name: Cancer/Testis Antigen


subject: UMLS:C3813556


subject: UMLS:C3813556


subject: PR:000050337

subject_name: mature calcitonin


subject: PR:000050337


subject: PR:000050337


subject: CHEBI:8687

subject_name: Pyrvinium

object_name: gastric neoplasm


subject: UNII:O43472U9X8

subject_name: Obinutuzumab


subject: CHEBI:36796

subject_name: duloxetine

object_name: Parkinson disease


subject: UMLS:C0770246

subject_name: PROTEIN SUPPLEMENTS

object_name: sarcopenia


subject: UMLS:C0770246

object_name: Muscle Atrophy


subject: PR:000030722

subject_name: palmitoyltransferase ZDHHC4

object_name: HER2 positive breast carcinoma


subject: UMLS:C0042210

subject_name: Vaccines


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: GTOPDB:8932

subject_name: pepinemab


subject: UNII:BPZ4A29SYE

subject_name: PEPINEMAB


subject: UMLS:C3272653


subject: GTOPDB:8451

subject_name: demcizumab

object_name: non-small cell lung carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2109384

subject_name: DEMCIZUMAB


subject: UMLS:C2698134


subject: CHEBI:3181

subject_name: Bromocriptine

object_name: euthyroid Graves orbitopathy


subject: CHEBI:3181

object_name: endocrine exophthalmos


subject: CHEBI:50673

subject_name: Methimazole


subject: CHEBI:50673


subject: CHEBI:7986

subject_name: Pentoxifylline


subject: CHEBI:7986


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: aggressive systemic mastocytosis


subject: CHEBI:2038

subject_name: Azacitidine


subject: UMLS:C5556656

subject_name: D816V-mutant KIT Inhibitor BLU-263


subject: PR:000022493

object_name: Vertical Disease Transmission


subject: PR:000022493

object_name: pregnancy disorder


subject: PUBCHEM.COMPOUND:77335690

subject_name: Velpatasvir


subject: PUBCHEM.COMPOUND:77335690


subject: CHEBI:188219

object_name: schizophrenia


subject: CHEBI:36005

subject_name: docosahexaenoic acid

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:36005

object_name: metabolic syndrome X


subject: CHEBI:16016

subject_name: Glycerone


subject: CHEBI:16016


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28689


subject: CHEBI:28125

subject_name: Doconexent


subject: CHEBI:28125


subject: CHEBI:37144

subject_name: epichlorohydrin


subject: CHEBI:37144


subject: CHEBI:28364

subject_name: Icosapent


subject: CHEBI:28364


subject: PR:000016352

subject_name: metalloproteinase inhibitor 1


subject: PR:000016352


subject: PUBCHEM.COMPOUND:3367

object_name: Disseminated Malignant Neoplasm


subject: PUBCHEM.COMPOUND:3367

object_name: Embolism, Tumor


subject: PUBCHEM.COMPOUND:3367

object_name: Neoplasm Metastasis


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:31824

subject_name: Mesna


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:17905


subject: CHEBI:17905


subject: UMLS:C4039583

subject_name: Chimeric antigen receptor


subject: UMLS:C4039583


subject: UMLS:C4039583


subject: GTOPDB:13924

subject_name: mazdutide

object_name: alcohol abuse


subject: GTOPDB:13924

object_name: alcohol dependence


subject: CHEMBL.COMPOUND:CHEMBL5095358

subject_name: MAZDUTIDE


subject: CHEMBL.COMPOUND:CHEMBL5095358


subject: UMLS:C5565538


subject: UMLS:C5565538


subject: CHEBI:174615

object_name: acute biphenotypic leukemia


subject: CHEBI:174615

object_name: mixed phenotype acute leukemia


subject: CHEBI:174615

object_name: acute leukemia of ambiguous lineage


subject: CHEBI:174615

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:174615

object_name: acute leukemia


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: PUBCHEM.COMPOUND:3367

object_name: adult lymphoma


subject: PUBCHEM.COMPOUND:3367

object_name: lymphoma


subject: PUBCHEM.COMPOUND:3367

object_name: pediatric lymphoma


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339

object_name: acute lymphoblastic leukemia


subject: CHEBI:82339

object_name: acute myeloid leukemia


subject: CHEBI:82339

object_name: Myelodysplasia


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: UNII:2P471X1Z11

subject_name: Omalizumab

object_name: Hypersensitivity reaction caused by food


subject: UMLS:C0910794


subject: CHEBI:2549

subject_name: Albuterol

object_name: cystic fibrosis


subject: CHEBI:9398

subject_name: Tamsulosin

object_name: Urinary Retention


subject: CHEBI:9398

object_name: Urinary Retention, CTCAE


subject: UNII:TUK9QB44B0

object_name: Tumor Mass


subject: UMLS:C5392518


subject: CHEBI:49140

object_name: neoplasm


subject: CHEBI:49140


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)


subject: CHEBI:31617


subject: CHEBI:91450

subject_name: Sapanisertib

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:91450

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:91450

object_name: Plasma cell myeloma refractory


subject: CHEBI:91450

object_name: Advanced Lymphoma


subject: CHEBI:91450

object_name: Refractory Lymphoma


subject: UMLS:C4287716

object_name: autoimmune thrombocytopenia


subject: UMLS:C4287716

object_name: thrombocytopenia due to immune destruction


subject: UMLS:C4287716

object_name: autoimmune thrombocytopenic purpura


subject: CHEBI:17688

subject_name: Nicotine

object_name: nicotine dependence


subject: CHEBI:59594

subject_name: Colesevelam

object_name: type 2 diabetes mellitus


subject: CHEBI:59594

object_name: Diabetes


subject: CHEBI:59594

object_name: diabetes mellitus


subject: MESH:D015164

subject_name: Vaccines, Inactivated

object_name: hand, foot and mouth disease


subject: MESH:D015164

object_name: herpangina


subject: CHEBI:9168

subject_name: Sirolimus

object_name: membranous glomerulonephritis


subject: CHEBI:49005

subject_name: Deferasirox

object_name: transfusional hemosiderosis


subject: CHEBI:2666

subject_name: Amitriptyline

object_name: endogenous depression


subject: CHEBI:2666

object_name: major depressive disorder


subject: CHEBI:7936

subject_name: Paroxetine


subject: CHEBI:7936


subject: UMLS:C1962503

subject_name: Seroquel XR

object_name: generalized anxiety disorder


subject: UMLS:C1962503


subject: UMLS:C1962503


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: intracerebral hemorrhage


subject: DRUGBANK:DB17177

object_name: glioblastoma


subject: DRUGBANK:DB17177

object_name: Childhood Glioblastoma


subject: DRUGBANK:DB17177

object_name: adult glioblastoma


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UNII:ASU841TV0X

subject_name: Veledimex


subject: UNII:ASU841TV0X


subject: UNII:ASU841TV0X


subject: UMLS:C4086733

subject_name: EPO 018B

object_name: chronic kidney disease


subject: GTOPDB:4934

subject_name: G-CSF

object_name: acute myeloid leukemia by FAB classification


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:50729

subject_name: Mitoxantrone


subject: CHEBI:50729

object_name: acute myeloid leukemia


subject: PUBCHEM.COMPOUND:16129681

subject_name: Ghrih-A

object_name: liver cirrhosis


subject: PUBCHEM.COMPOUND:16129681

object_name: thrombophilia due to thrombin defect


subject: PUBCHEM.COMPOUND:16129681

object_name: Venous thrombosis after immobility


subject: PUBCHEM.COMPOUND:16129681

object_name: varicose veins


subject: PUBCHEM.COMPOUND:16129681

object_name: Hemorrhage


subject: PUBCHEM.COMPOUND:53481605

subject_name: Somatostatin


subject: PUBCHEM.COMPOUND:53481605


subject: PUBCHEM.COMPOUND:53481605


subject: PUBCHEM.COMPOUND:53481605


subject: PUBCHEM.COMPOUND:53481605


subject: CHEBI:6706

subject_name: Mecamylamine

object_name: diabetic macular edema


subject: CHEBI:231614

object_name: trabecular adenocarcinoma


subject: CHEBI:231614

object_name: cutaneous neuroendocrine carcinoma


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol


subject: PUBCHEM.COMPOUND:521372

object_name: Brain Stem Glioblastoma


subject: PUBCHEM.COMPOUND:521372

object_name: glioma susceptibility 1


subject: PUBCHEM.COMPOUND:521372

object_name: plasma cell myeloma


subject: PUBCHEM.COMPOUND:521372

object_name: colon cancer


subject: PUBCHEM.COMPOUND:521372

object_name: pancreatic neoplasm


subject: PUBCHEM.COMPOUND:521372

object_name: exocrine pancreatic carcinoma


subject: PUBCHEM.COMPOUND:521372

object_name: malignant pancreatic neoplasm


subject: PUBCHEM.COMPOUND:521372

object_name: gallbladder cancer


subject: PUBCHEM.COMPOUND:521372

object_name: rectal carcinoma


subject: PUBCHEM.COMPOUND:521372

object_name: rectal cancer


subject: PUBCHEM.COMPOUND:521372

object_name: liver cancer


subject: PUBCHEM.COMPOUND:521372

object_name: liver carcinoma


subject: CHEBI:174379

object_name: Postoperative ileus


subject: UMLS:C3540037

subject_name: CALCIUM SUPPLEMENTS

object_name: postmenopausal osteoporosis


subject: UMLS:C1141002

subject_name: prune preparation


subject: CHEBI:25805

subject_name: oxygen atom

object_name: Ehlers-Danlos syndrome


subject: CHEBI:15379

subject_name: Oxygen


subject: CHEBI:193137

object_name: Metastatic malignant neoplasm to pancreas


subject: UMLS:C2984020


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: CHEBI:45863

subject_name: Paclitaxel


subject: GTOPDB:13876

subject_name: nipocalimab

object_name: Sicca Syndrome


subject: UNII:87M90CV8NC

subject_name: NIPOCALIMAB


subject: UMLS:C5417823


subject: CHEBI:16069

subject_name: Imidazole

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:16069

object_name: clear cell renal carcinoma


subject: CHEBI:16069

object_name: renal cell adenocarcinoma


subject: CHEBI:16069

object_name: renal cell carcinoma


subject: CHEBI:16069

object_name: Metastatic Renal Cell Carcinoma


subject: CHEBI:16069

object_name: Metastatic Renal Cell Cancer


subject: CHEBI:16069

object_name: renal carcinoma


subject: CHEBI:16069

object_name: kidney neoplasm


subject: CHEBI:16069

object_name: kidney cancer


subject: CHEBI:39168

subject_name: Imidacloprid


subject: CHEBI:39168


subject: CHEBI:39168


subject: CHEBI:39168


subject: CHEBI:39168


subject: CHEBI:39168


subject: CHEBI:39168


subject: CHEBI:39168


subject: CHEBI:39168


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: Other respiratory problems after birth


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: Fetal anomaly


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: Macrosomia


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: inflammatory bowel disease 1


subject: CHEBI:73604

object_name: Crohn disease


subject: CHEBI:2668

subject_name: Amlodipine

object_name: myotonic dystrophy type 1


subject: CHEBI:2668

object_name: myotonic dystrophy


subject: PUBCHEM.COMPOUND:152165

object_name: Inflammation


subject: PUBCHEM.COMPOUND:152165

object_name: Overweight


subject: PUBCHEM.COMPOUND:152165

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PUBCHEM.COMPOUND:152165

object_name: obesity


subject: PUBCHEM.COMPOUND:152165

object_name: Obesity, CTCAE


subject: CHEBI:47381

subject_name: Diclofenac


subject: CHEBI:47381


subject: CHEBI:47381


subject: CHEBI:47381


subject: CHEBI:47381


subject: UMLS:C1328192

subject_name: ADI PEG20

object_name: Childhood Soft Tissue Sarcoma


subject: UMLS:C1328192

object_name: Adult Soft Tissue Sarcoma


subject: UMLS:C1328192

object_name: sarcoma


subject: UMLS:C1328192

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UMLS:C1328192

object_name: soft tissue sarcoma


subject: UMLS:C1328192

object_name: telomere syndrome


subject: UMLS:C1328192

object_name: recessive X-linked ichthyosis


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:31824

subject_name: Mesna


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:6413

subject_name: Letrozole

object_name: Hypoxemia


subject: CHEBI:6413

object_name: Hypoxia, CTCAE


subject: CHEBI:8869

subject_name: Risedronic acid

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:8869

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:8869

object_name: Osteoporosis, CTCAE 3.0


subject: CHEBI:50790

subject_name: EC 1.14.14.14 (aromatase) inhibitor

object_name: Childhood Breast Carcinoma


subject: CHEBI:50790

object_name: breast carcinoma


subject: CHEBI:50790

object_name: breast cancer


subject: UMLS:C0593802

subject_name: Aromatase Inhibitors


subject: UMLS:C0593802


subject: UMLS:C0593802


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Stomach cancer


subject: CHEBI:31355

object_name: gastric cancer


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:4636

subject_name: Diphenhydramine


subject: CHEBI:4636


subject: CHEBI:4975

subject_name: Famotidine


subject: CHEBI:4975


subject: UNII:YZS3R7LP44

subject_name: Palonosetron


subject: UNII:YZS3R7LP44


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Non-small cell lung cancer stage IIIB


subject: UNII:52CMI0WC3Y

object_name: Non-small cell lung cancer stage IIIA


subject: UNII:52CMI0WC3Y

object_name: Carcinoma bronchiogenic cell type unspecified stage III


subject: UNII:52CMI0WC3Y

object_name: respiratory tract neoplasm


subject: UNII:52CMI0WC3Y

object_name: lung disorder


subject: UNII:52CMI0WC3Y

object_name: neoplasm of thorax


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:8871

subject_name: Risperidone

object_name: conduct disorder


subject: CHEBI:8871

object_name: disruptive behavior disorder


subject: CHEBI:8871

object_name: oppositional defiant disorder


subject: CHEBI:74705

subject_name: Met-Leu

object_name: central precocious puberty


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Stage IA Pancreatic Cancer AJCC v8


subject: CHEBI:31348

object_name: Stage IA Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:31348

object_name: stage IB pancreatic cancer


subject: CHEBI:31348

object_name: Stage IB Pancreatic Cancer AJCC v8


subject: CHEBI:31348

object_name: Stage IB Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:31348

object_name: stage IIB pancreatic cancer


subject: CHEBI:31348

object_name: Stage IIB Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:31348

object_name: Stage IIB Pancreatic Cancer AJCC v8


subject: CHEBI:31348

object_name: Stage IIA Pancreatic Cancer AJCC v8


subject: CHEBI:31348

object_name: Stage IIA Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:31348

object_name: stage IIA pancreatic cancer


subject: CHEBI:63633

subject_name: Triptorelin

object_name: infertility


subject: CHEBI:9943

subject_name: Venlafaxine

object_name: obesity due to congenital leptin deficiency


subject: CHEBI:9943

object_name: obesity due to leptin receptor gene deficiency


subject: CHEBI:9943

object_name: morbid obesity


subject: CHEBI:36796

subject_name: duloxetine

object_name: mood disorder


subject: CHEBI:36796

object_name: mental disorder


subject: CHEBI:36796

object_name: psychiatric disorder


subject: CHEBI:36791

subject_name: Escitalopram


subject: CHEBI:36791


subject: CHEBI:36791


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:3723


subject: CHEBI:3723


subject: CHEBI:5118

subject_name: Fluoxetine

object_name: major depressive disorder


subject: CHEBI:5118


subject: CHEBI:5118


subject: CHEBI:5118


subject: CHEBI:134716

subject_name: Brexpiprazole


subject: CHEBI:134716


subject: CHEBI:134716


subject: CHEBI:9123

subject_name: Sertraline


subject: CHEBI:9123


subject: CHEBI:9123


subject: CHEBI:9123


subject: CHEBI:95165

object_name: Metastatic Renal Cell Carcinoma


subject: CHEBI:95165

object_name: Metastatic Renal Cell Cancer


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: CHEBI:91402

subject_name: linsitinib

object_name: liver cancer


subject: CHEBI:91402

object_name: liver neoplasm


subject: CHEBI:91402

object_name: Adult Liver Carcinoma


subject: CHEBI:91402

object_name: liver carcinoma


subject: UMLS:C2346449

subject_name: OSI 906


subject: UMLS:C2346449


subject: UMLS:C2346449


subject: UMLS:C2346449


subject: UMLS:C1608718

object_name: coronary artery disorder


subject: UMLS:C1608718

object_name: coronary atherosclerosis


subject: UMLS:C1608718

object_name: gout


subject: CHEBI:68558

subject_name: Ticagrelor


subject: CHEBI:145371

subject_name: Binimetinib

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:145371

object_name: BRAF V600 Protein Variation


subject: CHEBI:145371

object_name: melanoma


subject: UNII:8L7891MRB6

subject_name: Encorafenib


subject: UNII:8L7891MRB6


subject: UNII:8L7891MRB6


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Recurrent Primary Peritoneal Carcinoma


subject: CHEBI:175901

object_name: Recurrent Fallopian Tube Carcinoma


subject: CHEBI:175901

object_name: Recurrent ovarian cancer


subject: CHEBI:175901

object_name: Breast cancer recurrent


subject: UNII:98DE7VN88D

subject_name: huMov 19


subject: UNII:98DE7VN88D


subject: UNII:98DE7VN88D


subject: UNII:98DE7VN88D

object_name: triple-negative breast carcinoma


subject: UMLS:C3640818


subject: UMLS:C3640818


subject: UMLS:C3640818


subject: UMLS:C3640818


subject: CHEBI:50730

subject_name: Montelukast

object_name: dyspepsia


subject: CHEBI:50730

object_name: Dyspepsia, CTCAE


subject: CHEBI:50730

object_name: eosinophilic gastroenteritis


subject: UMLS:C4287586

subject_name: Ceftazidime/Avibactam Sodium

object_name: Sepsis


subject: CHEBI:47519

subject_name: Ketoconazole

object_name: prostate carcinoma


subject: CHEBI:47519

object_name: prostate cancer


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: CHEBI:17650


subject: CHEBI:95165

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:95165

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:95165

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:95165

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: CHEBI:95165

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:95165

object_name: adult acute myeloid leukemia with del(5q)


subject: CHEBI:95165

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEBI:95165

object_name: Untreated Adult Acute Myeloid Leukemia


subject: CHEBI:95165

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:95165

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:168243

subject_name: Valproic acid glucuronide


subject: CHEBI:168243


subject: CHEBI:168243


subject: CHEBI:168243


subject: CHEBI:168243


subject: CHEBI:168243


subject: CHEBI:168243


subject: CHEBI:168243


subject: CHEBI:168243


subject: CHEBI:168243


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:32599

object_name: Acute Stroke


subject: CHEBI:32599

object_name: Acute Stroke Related to COVID-19


subject: GTOPDB:9802

object_name: Myasthenia Gravis, Generalized


subject: UMLS:C4548814


subject: CHEBI:9907

subject_name: ursodiol

object_name: heart failure


subject: CHEBI:9907

object_name: congestive heart failure


subject: CHEBI:231683

subject_name: Anakinra

object_name: alcoholic hepatitis


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: CHEBI:7986

subject_name: Pentoxifylline


subject: CHEBI:35176

subject_name: Zinc sulfate


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: pudendal neuralgia


subject: CHEBI:3215

object_name: Pudendal Nerve Entrapment Syndrome


subject: CHEBI:3215

object_name: Chronic pelvic pain syndrome


subject: UMLS:C3827044

subject_name: Toca FC

object_name: glioblastoma


subject: UMLS:C3827044

object_name: Brain Stem Glioblastoma


subject: UMLS:C3827044

object_name: glioma susceptibility 1


subject: UMLS:C3827044

object_name: Childhood Anaplastic Oligodendroglioma


subject: UMLS:C3827044

object_name: anaplastic oligodendroglioma


subject: UMLS:C3827044

object_name: Adult Anaplastic Oligodendroglioma


subject: UMLS:C3827044

object_name: Childhood Anaplastic Oligoastrocytoma


subject: UMLS:C3827044

object_name: anaplastic oligoastrocytoma


subject: UMLS:C3827044

object_name: Grade III Childhood Astrocytoma


subject: UMLS:C3827044

object_name: Adult Anaplastic Astrocytoma


subject: UMLS:C3827044

object_name: anaplastic astrocytoma


subject: CHEBI:6741

subject_name: Meloxicam

object_name: osteoarthritis, knee


subject: GTOPDB:7989

subject_name: sirukumab

object_name: rheumatoid arthritis


subject: CHEMBL.COMPOUND:CHEMBL1743071

subject_name: SIRUKUMAB


subject: UMLS:C3254570


subject: CHEBI:50859

subject_name: Bexarotene

object_name: adult lymphoma


subject: CHEBI:50859

object_name: lymphoma


subject: CHEBI:50859

object_name: pediatric lymphoma


subject: CHEBI:184662

object_name: hepatitis C


subject: CHEMBL.COMPOUND:CHEMBL256907

subject_name: maraviroc


subject: CHEBI:63608

subject_name: Maraviroc


subject: CHEBI:48273

subject_name: Rizatriptan

object_name: Acute migraine


subject: UNII:71492GE1FX

subject_name: Benralizumab

object_name: eosinophilic granulomatosis with polyangiitis


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: retinal detachment


subject: UNII:2S9ZZM9Q9V

object_name: Retinal Detachment, CTCAE 3.0


subject: UNII:2S9ZZM9Q9V

object_name: Retinal Detachment, CTCAE 5.0


subject: GTOPDB:13908

subject_name: telisotuzumab vedotin

object_name: non-small cell lung carcinoma


subject: UNII:976X9VXC3Z


subject: UMLS:C3896932


subject: UNII:RM16A4BA8R

subject_name: OBEXELIMAB

object_name: Multiple sclerosis relapse


subject: UMLS:C5139908

subject_name: Obexelimab


subject: CHEBI:94708

subject_name: Diacerein

object_name: osteoarthritis


subject: UMLS:C5706554

subject_name: Anti-DLL3/CD3 Bispecific Antibody QLS31904

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:72292

subject_name: Bedaquiline

object_name: multidrug-resistant tuberculosis


subject: UNII:D959AE5USF

subject_name: clofazimine


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN


subject: CHEBI:63598

subject_name: Levofloxacin


subject: CHEBI:63607

subject_name: Linezolid


subject: CHEBI:90001

subject_name: cystathionine ketimine

object_name: cholangiocarcinoma


subject: CHEBI:90001

object_name: digestive system cancer


subject: CHEBI:90001

object_name: colorectal cancer


subject: CHEBI:90001

object_name: colorectal carcinoma


subject: CHEBI:90001

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:90001

object_name: liver carcinoma


subject: CHEBI:90001

object_name: Stomach cancer


subject: CHEBI:90001

object_name: gastric cancer


subject: CHEBI:90001

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:28082


subject: CHEBI:28082


subject: CHEBI:28082


subject: CHEBI:28082


subject: CHEBI:28082


subject: CHEBI:28082


subject: CHEBI:28082


subject: CHEBI:28082


subject: CHEBI:28082


subject: UMLS:C3813556

subject_name: Cancer/Testis Antigen


subject: UMLS:C3813556


subject: UMLS:C3813556


subject: UMLS:C3813556


subject: UMLS:C3813556


subject: UMLS:C3813556


subject: UMLS:C3813556


subject: UMLS:C3813556


subject: UMLS:C3813556


subject: PR:000050337

subject_name: mature calcitonin


subject: PR:000050337


subject: PR:000050337


subject: PR:000050337


subject: PR:000050337


subject: PR:000050337


subject: PR:000050337


subject: PR:000050337


subject: PR:000050337


subject: CHEBI:151315

subject_name: Heparin

object_name: Complication of extracorporeal circulation


subject: KEGG.COMPOUND:C00374


subject: MESH:C476332

object_name: hand, foot and mouth disease


subject: CHEMBL.COMPOUND:CHEMBL4297257

subject_name: ALBUVIRTIDE

object_name: HIV-1 infection


subject: UMLS:C3493164

subject_name: albuvirtide


subject: CHEBI:8863

subject_name: Riluzole

object_name: Compulsion


subject: CHEBI:8863

object_name: pervasive developmental disorder


subject: CHEBI:8863

object_name: autism


subject: CHEBI:8863

object_name: autism spectrum disorder


subject: CHEBI:8863

object_name: Asperger syndrome


subject: CHEBI:8863

object_name: developmental disability


subject: GTOPDB:8965

subject_name: fasinumab

object_name: Low back pain


subject: CHEMBL.COMPOUND:CHEMBL2109528

subject_name: FASINUMAB


subject: UMLS:C4519593


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: Depressed mood


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: Cancer patients and suicide and depression


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: Depressed - symptom


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: Depression, CTCAE


subject: UMLS:C2826382

object_name: non-small cell lung carcinoma


subject: CHEBI:125354

subject_name: Plerixafor

object_name: non-Hodgkin lymphoma


subject: UMLS:C5834504

subject_name: MTC-DOX for Injection

object_name: liver carcinoma


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEMBL.COMPOUND:CHEMBL4650469

subject_name: DEPEMOKIMAB

object_name: asthma


subject: UMLS:C5448037

subject_name: Depemokimab


subject: CHEBI:34385

subject_name: Dalfampridine

object_name: Nerve injury


subject: CHEBI:70839

subject_name: Dasatinib

object_name: Childhood Solid Neoplasm


subject: CHEBI:70839

object_name: Adult Solid Neoplasm


subject: CHEBI:70839

object_name: Solid Neoplasm


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:63605

subject_name: Ixabepilone


subject: CHEBI:63605


subject: CHEBI:90225

subject_name: Rubitecan

object_name: ovarian cancer


subject: CHEBI:90225

object_name: ovarian neoplasm


subject: CHEBI:90225

object_name: ovarian carcinoma


subject: CHEBI:90225

object_name: peritoneum cancer


subject: CHEBI:78549

subject_name: Pipamperone


subject: CHEBI:78549


subject: CHEBI:78549


subject: CHEBI:78549


subject: UNII:6A901E312A

subject_name: Panitumumab

object_name: colon carcinoma


subject: UNII:6A901E312A

object_name: colon cancer


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Carcinoma of urinary bladder, invasive


subject: CHEBI:175901

object_name: urinary bladder carcinoma


subject: CHEBI:175901

object_name: urinary bladder cancer


subject: CHEBI:175901

object_name: childhood bladder carcinoma


subject: CHEBI:36796

subject_name: duloxetine

object_name: Stress urinary incontinence


subject: UNII:WQJ8L8YJ7U

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UNII:WQJ8L8YJ7U

object_name: chronic leukemia


subject: DRUGBANK:DB17307


subject: DRUGBANK:DB17307


subject: CHEBI:45783

subject_name: Imatinib


subject: PUBCHEM.COMPOUND:21628493

subject_name: ESTROGEN

object_name: Alzheimer disease


subject: CHEBI:50114

subject_name: estrogen


subject: CHEBI:4903

subject_name: Ethinylestradiol


subject: UMLS:C2936882

subject_name: Estrogen [EPC]


subject: CHEBI:63717

subject_name: Tenofovir disoproxil

object_name: hepatitis B


subject: CHEBI:63717

object_name: Vertical Disease Transmission


subject: UMLS:C0081420

subject_name: AaIT neurotoxin, Androctonus australis

object_name: Disorder of immune reconstitution


subject: UMLS:C0081420

object_name: HIV infection


subject: CHEBI:44423

subject_name: Hydroxyurea

object_name: Severe Acute Malnutrition


subject: CHEBI:73604

subject_name: Lys-Gly


subject: CHEBI:73604

object_name: sickle cell disease


subject: CHEBI:73604

object_name: inflammatory bowel disease


subject: CHEBI:73604

object_name: irritable bowel syndrome


subject: CHEBI:73604

object_name: colitis


subject: CHEBI:73604

object_name: Colitis, CTCAE


subject: CHEBI:27504

subject_name: Mitomycin

object_name: myopia


subject: CHEBI:15843

subject_name: Arachidonate

object_name: Adverse reaction to rabies vaccine


subject: CHEBI:3654

subject_name: Chlorthalidone

object_name: Chronic uremia


subject: CHEBI:63610

subject_name: Misoprostol

object_name: Induced Abortion Finding


subject: UMLS:C2984026

subject_name: Heat-Treated Varicella-Zoster Virus Vaccine V212

object_name: herpes zoster


subject: CHEBI:31300

subject_name: BOSENTAN

object_name: congenital heart disease


subject: CHEBI:51450

subject_name: Bosentan


subject: GTOPDB:2943

subject_name: secretin

object_name: Injury of body of pancreas


subject: CHEBI:232390


subject: CHEBI:3310

subject_name: Calcium acetate

object_name: chronic kidney disease


subject: CHEBI:3310

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:41423

subject_name: Celecoxib

object_name: Functional Status


subject: CHEBI:41423

object_name: Function Axis


subject: CHEBI:6121

subject_name: Ketamine

object_name: delirium


subject: CHEBI:6121

object_name: Delirium, CTCAE


subject: CHEBI:73604


subject: CHEBI:73604


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Delirium in old age


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: PUBCHEM.COMPOUND:3222

object_name: metastatic melanoma


subject: CHEBI:4784

subject_name: Enalapril


subject: CHEBI:8499

subject_name: Propranolol


subject: CHEBI:17858

subject_name: oxiglutatione

object_name: type 2 diabetes mellitus


subject: CHEBI:17858

object_name: Insulin resistance


subject: CHEBI:17858

object_name: hyperlipidemia


subject: CHEBI:17858

object_name: hyperlipoproteinemia


subject: CHEBI:17858

object_name: Hyperlipidemia, CTCAE


subject: CHEBI:17858

object_name: Serum lipids high (finding)


subject: CHEBI:17858

object_name: hypertension


subject: CHEBI:17858

object_name: Hypertension, CTCAE


subject: CHEBI:17858

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:17858

object_name: obesity


subject: CHEBI:17858

object_name: Obesity, CTCAE


subject: CHEBI:177535

subject_name: L-Glutathione (reduced)


subject: CHEBI:177535


subject: CHEBI:177535


subject: CHEBI:177535


subject: CHEBI:177535


subject: CHEBI:177535


subject: CHEBI:177535


subject: CHEBI:177535


subject: CHEBI:177535


subject: CHEBI:177535


subject: CHEBI:177535


subject: CHEBI:57925


subject: CHEBI:57925


subject: CHEBI:57925


subject: CHEBI:57925


subject: CHEBI:57925


subject: CHEBI:57925


subject: CHEBI:57925


subject: CHEBI:57925


subject: CHEBI:57925


subject: CHEBI:57925


subject: CHEBI:57925


subject: CHEBI:177258

subject_name: Cytidine 2',3'-cyclic phosphate


subject: CHEBI:177258


subject: CHEBI:177258


subject: CHEBI:177258


subject: CHEBI:177258


subject: CHEBI:177258


subject: CHEBI:177258


subject: CHEBI:177258


subject: CHEBI:177258


subject: CHEBI:177258


subject: CHEBI:177258


subject: CHEBI:16856

subject_name: Glutathione


subject: CHEBI:16856


subject: CHEBI:16856


subject: CHEBI:16856


subject: CHEBI:16856


subject: CHEBI:16856


subject: CHEBI:16856


subject: CHEBI:16856


subject: CHEBI:16856


subject: CHEBI:16856


subject: CHEBI:16856


subject: CHEBI:28939

subject_name: Acetylcysteine


subject: CHEBI:28939


subject: CHEBI:28939


subject: CHEBI:28939


subject: CHEBI:28939


subject: CHEBI:28939


subject: CHEBI:28939


subject: CHEBI:28939


subject: CHEBI:28939


subject: CHEBI:28939


subject: CHEBI:39867

subject_name: Valproic acid

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:39867

object_name: amyotrophic lateral sclerosis


subject: PUBCHEM.COMPOUND:137380252

object_name: malaria


subject: UMLS:C0034131

subject_name: Tubersol

object_name: tuberculosis


subject: UNII:7CAZ46X8EL

subject_name: SEPOFARSEN

object_name: Leber congenital amaurosis


subject: UNII:7CAZ46X8EL

object_name: CEP290-related ciliopathy


subject: UNII:7CAZ46X8EL

object_name: Leber congenital amaurosis 10


subject: UNII:7CAZ46X8EL

object_name: eye disorder


subject: UNII:7CAZ46X8EL

object_name: Neurologic Manifestations


subject: UNII:7CAZ46X8EL

object_name: Sensation Disorders


subject: UNII:7CAZ46X8EL

object_name: Eye Diseases, Hereditary


subject: UNII:7CAZ46X8EL

object_name: vision disorder


subject: UNII:7CAZ46X8EL

object_name: retinal disease


subject: UNII:7CAZ46X8EL

object_name: blindness


subject: PUBCHEM.COMPOUND:126480263

subject_name: NEROFE

object_name: acute myeloid leukemia


subject: UNII:SR717JCM7M


subject: UMLS:C2974969

subject_name: Nerofe


subject: UNII:3BY9Z3M34G

subject_name: Golidocitinib

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: UNII:3BY9Z3M34G

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: UNII:2P6O7CFW5K

subject_name: Triheptanoin

object_name: alternating hemiplegia of childhood


subject: UNII:O43472U9X8

subject_name: Obinutuzumab

object_name: marginal zone lymphoma


subject: UNII:O43472U9X8

object_name: MALT lymphoma


subject: RXCUI:901639

subject_name: Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine Prefilled Syringe

object_name: pneumococcal infection


subject: DRUGBANK:DB18396

object_name: skin squamous cell carcinoma


subject: DRUGBANK:DB18396

object_name: cutaneous squamous cell carcinoma


subject: DRUGBANK:DB18396

object_name: basal cell carcinoma


subject: DRUGBANK:DB18396

object_name: skin basal cell carcinoma


subject: CHEBI:87681

subject_name: Ranolazine

object_name: Premature ventricular contraction


subject: CHEBI:87681

object_name: Ventricular Premature Complex by ECG Finding


subject: UNII:K3978U665M

object_name: HIV-1 infection


subject: CHEBI:55352

subject_name: (R)-Atenolol

object_name: aneurysm


subject: CHEBI:2904

subject_name: Atenolol


subject: CHEBI:93414

subject_name: Tesmilifene

object_name: Carcinoma breast stage IV


subject: CHEBI:6339

subject_name: Etoricoxib

object_name: ankylosing spondylitis


subject: CHEBI:6339

object_name: rheumatoid arthritis


subject: CHEBI:6339

object_name: osteoarthritis


subject: CHEBI:6339

object_name: arthritis


subject: CHEBI:6339

object_name: Arthritis, CTCAE


subject: CHEBI:6339

object_name: gout


subject: CHEBI:145499

subject_name: Donepezil

object_name: migraine


subject: CHEBI:4696

subject_name: donepezil hydrochloride


subject: CHEBI:60791

subject_name: Xylocard

object_name: brain small vessel disease 3


subject: CHEBI:6456

subject_name: Lidocaine


subject: UMLS:C0733796

subject_name: Gastrografin

object_name: meconium ileus


subject: UMLS:C0733796

object_name: intestinal obstruction in the newborn due to guanylate cyclase 2C deficiency


subject: UMLS:C0733796

object_name: Light for dates


subject: CHEBI:47499

subject_name: Imipramine

object_name: Stress urinary incontinence


subject: CHEBI:47499

object_name: Bowel incontinence


subject: CHEBI:47499

object_name: Fecal Incontinence, CTCAE


subject: RXCUI:8375

subject_name: placebo Oral Tablet


subject: RXCUI:8375


subject: RXCUI:8375


subject: UMLS:C3537244

subject_name: Insulins

object_name: type 2 diabetes mellitus


subject: CHEBI:82339

subject_name: Merphalan

object_name: non-Hodgkin lymphoma


subject: CHEBI:82339

object_name: Hodgkin Disease


subject: PUBCHEM.COMPOUND:9953630

subject_name: CODEINE PHOSPHATE

object_name: Cough


subject: PUBCHEM.COMPOUND:9953630

object_name: Cough, CTCAE


subject: UNII:GSL05Y1MN6

subject_name: Codeine phosphate hemihydrate


subject: UNII:GSL05Y1MN6


subject: PUBCHEM.COMPOUND:2828


subject: PUBCHEM.COMPOUND:2828


subject: CHEBI:16714

subject_name: Codeine


subject: CHEBI:16714


subject: PUBCHEM.COMPOUND:49865963

subject_name: TRABECTEDIN

object_name: leiomyosarcoma


subject: PUBCHEM.COMPOUND:49865963

object_name: Childhood Leiomyosarcoma


subject: PUBCHEM.COMPOUND:49865963

object_name: Adult Leiomyosarcoma


subject: PUBCHEM.COMPOUND:3199

subject_name: ecteinascidin 743


subject: PUBCHEM.COMPOUND:3199


subject: PUBCHEM.COMPOUND:3199


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Complication of renal dialysis


subject: CHEBI:7772

subject_name: omeprazole

object_name: Gastroesophageal Reflux Disease, CTCAE


subject: CHEBI:77260

subject_name: Omeprazole


subject: UNII:5UPW5HJW3O

subject_name: EFBEMALENOGRASTIM ALFA

object_name: cervical cancer


subject: UNII:5UPW5HJW3O

object_name: cervical carcinoma


subject: UNII:5UPW5HJW3O

object_name: ovarian cancer


subject: UNII:5UPW5HJW3O

object_name: ovarian neoplasm


subject: UNII:5UPW5HJW3O

object_name: ovarian carcinoma


subject: UMLS:C3640969

subject_name: Recombinant dimeric g-csf fusion protein f627


subject: UMLS:C3640969


subject: UMLS:C3640969


subject: UMLS:C3640969


subject: UMLS:C3640969


subject: CHEBI:36704

subject_name: Imiquimod

object_name: alopecia areata


subject: CHEBI:36704

object_name: alopecia


subject: CHEBI:231351

subject_name: Telatinib

object_name: Stomach cancer


subject: CHEBI:231351

object_name: gastric cancer


subject: UNII:4T36H88UA7

subject_name: Apalutamide

object_name: High risk of recurrence, prostate cancer (PRCA)


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: Immune Tolerance


subject: CHEBI:61057

object_name: Immunosuppression


subject: CHEBI:61057

object_name: Decreased Immunologic Activity [PE]


subject: CHEBI:61057

object_name: Complication of transplanted liver


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:201431

subject_name: Cyclosporin H


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:7563

subject_name: N-nicotinoylglycine

object_name: retinal vein occlusion


subject: MESH:D009539

subject_name: Nicotinic Acids


subject: UMLS:C3714626

subject_name: Nicotinic Acid Drug Class


subject: CHEBI:15940

subject_name: Niacin


subject: UMLS:C3536880

subject_name: Nicotinic Acid [EPC]


subject: PUBCHEM.COMPOUND:4895

subject_name: Pred Forte


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:8452

subject_name: Proflavine

object_name: Anal high grade squamous intraepithelial lesion


subject: CHEBI:53760

subject_name: Eszopiclone

object_name: insomnia


subject: CHEBI:53760

object_name: Insomnia, CTCAE 3.0


subject: CHEBI:53760

object_name: Insomnia, CTCAE 5.0


subject: CHEBI:53760

object_name: rheumatoid arthritis


subject: CHEBI:135948

subject_name: Amifampridine

object_name: Myasthenia Gravis, Generalized


subject: CHEBI:36005

subject_name: docosahexaenoic acid

object_name: Neonatal disorder


subject: CHEBI:16016

subject_name: Glycerone


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28125

subject_name: Doconexent


subject: CHEBI:28918

subject_name: Epinephrine

object_name: hypoglycemia


subject: CHEBI:28918

object_name: Blood glucose below reference range (finding)


subject: CHEBI:28918

object_name: Hypoglycemia, CTCAE


subject: CHEBI:28918

object_name: diabetes mellitus


subject: CHEBI:28918

object_name: pure autonomic failure


subject: CHEBI:50731

subject_name: morphine sulfate pentahydrate


subject: CHEBI:50731


subject: CHEBI:50731


subject: CHEBI:50731


subject: CHEBI:50731


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:28645

subject_name: FRUCTOSE


subject: CHEBI:28645


subject: CHEBI:28645


subject: CHEBI:28645


subject: CHEBI:28645


subject: CHEBI:48095

subject_name: keto-D-fructose


subject: CHEBI:48095


subject: CHEBI:48095


subject: CHEBI:48095


subject: CHEBI:48095


subject: CHEBI:7459

subject_name: Naloxone


subject: CHEBI:7459


subject: CHEBI:7459


subject: CHEBI:7459


subject: CHEBI:7459


subject: CHEBI:16810

object_name: colorectal cancer


subject: CHEBI:16810

object_name: colorectal carcinoma


subject: CHEBI:16810

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:30915

subject_name: Oxogluric acid


subject: CHEBI:30915


subject: CHEBI:30915


subject: UMLS:C1291208

subject_name: alpha-Ketoglutarate


subject: UMLS:C1291208


subject: UMLS:C1291208


subject: UMLS:C1456745


subject: UMLS:C4520809

subject_name: Polyamine Analogue PG11047

object_name: adult lymphoma


subject: UMLS:C4520809

object_name: lymphoma


subject: UMLS:C4520809

object_name: pediatric lymphoma


subject: GTOPDB:9290

subject_name: elezanumab

object_name: Acute Ischemic Stroke


subject: GTOPDB:9290

object_name: Ischemic stroke


subject: UNII:SK1LVT23A1

subject_name: ELEZANUMAB


subject: UNII:SK1LVT23A1


subject: UMLS:C5139889


subject: UMLS:C5139889


subject: CHEBI:3347

subject_name: Candesartan

object_name: type 1 diabetes mellitus


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: Hodgkin Disease


subject: PUBCHEM.COMPOUND:1805

object_name: Adult Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:1805

object_name: Childhood Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:1805

object_name: lymphoma, non-Hodgkin, familial


subject: PUBCHEM.COMPOUND:1805

object_name: non-Hodgkin lymphoma


subject: PUBCHEM.COMPOUND:1805

object_name: Adult Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:1805

object_name: Childhood Non-Hodgkin Lymphoma


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:34523

subject_name: Acotiamide

object_name: Nonulcer dyspepsia


subject: CHEBI:49900

subject_name: Arsenous acid

object_name: cervical cancer


subject: CHEBI:49900

object_name: cervical carcinoma


subject: PUBCHEM.COMPOUND:518740

subject_name: Arsenic trioxide


subject: PUBCHEM.COMPOUND:518740


subject: CHEBI:30621

subject_name: diarsenic trioxide


subject: CHEBI:30621


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: PUBCHEM.COMPOUND:64987

object_name: hepatitis B


subject: CHEBI:63717

subject_name: Tenofovir disoproxil

object_name: chronic hepatitis B virus infection


subject: CHEBI:63625

subject_name: Tenofovir


subject: UMLS:C2830052

object_name: leukemia


subject: UMLS:C2830052

object_name: childhood leukemia


subject: UMLS:C2830052

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:91397

subject_name: Ibrutinib


subject: CHEBI:91397


subject: CHEBI:91397


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: Recurrent Childhood Glioblastoma


subject: UNII:GKF8S4C432

object_name: Recurrent Glioblastoma


subject: CHEBI:125427

object_name: lung cancer


subject: CHEBI:125427

object_name: lung neoplasm


subject: CHEBI:125427

object_name: lung carcinoma


subject: CHEBI:125427

object_name: precancerous condition


subject: CHEBI:125427

object_name: nicotine dependence


subject: UMLS:C3714610

subject_name: Calcitriol Drug Class


subject: UMLS:C3714610


subject: UMLS:C3714610


subject: UMLS:C3714610


subject: UMLS:C3714610


subject: CHEBI:17823

subject_name: Calcitriol


subject: CHEBI:17823


subject: CHEBI:17823


subject: CHEBI:17823


subject: CHEBI:17823


subject: UMLS:C0030956

subject_name: Peptides

object_name: peripheral arterial disease


subject: CHEBI:93775

subject_name: Amethopterin

object_name: primary central nervous system lymphoma


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:72690

subject_name: Pomalidomide


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:70746

subject_name: Dabigatran etexilate

object_name: Thromboembolism


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: Recurrent ovarian cancer


subject: UNII:6QVL057INT

object_name: Recurrent Endometrial Cancer


subject: UNII:6QVL057INT

object_name: Recurrent Fallopian Tube Carcinoma


subject: UNII:6QVL057INT

object_name: Recurrent Primary Peritoneal Carcinoma


subject: UNII:6QVL057INT

object_name: endometrial cancer


subject: UNII:6QVL057INT

object_name: uterine corpus cancer


subject: UNII:6QVL057INT

object_name: endometrial carcinoma


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UNII:NU90V55F8I

subject_name: Sarilumab


subject: UNII:NU90V55F8I


subject: UNII:NU90V55F8I


subject: UNII:NU90V55F8I


subject: UNII:NU90V55F8I


subject: UNII:NU90V55F8I


subject: UNII:NU90V55F8I


subject: UNII:I031V2H011

subject_name: Tocilizumab


subject: UNII:I031V2H011


subject: UNII:I031V2H011


subject: UNII:I031V2H011


subject: UNII:I031V2H011


subject: UNII:I031V2H011


subject: UNII:I031V2H011


subject: CHEMBL.COMPOUND:CHEMBL4594595

subject_name: UBAMATAMAB


subject: CHEMBL.COMPOUND:CHEMBL4594595


subject: CHEMBL.COMPOUND:CHEMBL4594595


subject: CHEMBL.COMPOUND:CHEMBL4594595


subject: CHEMBL.COMPOUND:CHEMBL4594595


subject: CHEMBL.COMPOUND:CHEMBL4594595


subject: CHEMBL.COMPOUND:CHEMBL4594595


subject: UMLS:C4727043

subject_name: Ubamatamab


subject: UMLS:C4727043


subject: UMLS:C4727043


subject: UMLS:C4727043


subject: UMLS:C4727043


subject: UMLS:C4727043


subject: UMLS:C4727043


subject: PUBCHEM.COMPOUND:54214995

subject_name: Sacubitril

object_name: essential hypertension


subject: UMLS:C1442960

subject_name: Turkey antigen

object_name: cesarean section; complications


subject: UMLS:C1442960

object_name: Postoperative shivering


subject: UMLS:C1442960

object_name: Magnesium sulfate causing adverse effects in therapeutic use


subject: DRUGBANK:DB10575

subject_name: Turkey


subject: DRUGBANK:DB10575


subject: DRUGBANK:DB10575


subject: UMLS:C4083042

subject_name: BRAF(V600E) Kinase Inhibitor RO5185426

object_name: melanoma


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:15940

subject_name: Niacin

object_name: nicotine dependence


subject: CHEBI:17154

subject_name: Nicotinamide


subject: CHEBI:139072


subject: CHEBI:8614

subject_name: Psilocybin


subject: UMLS:C2346821

subject_name: pidilizumab

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C2346821

object_name: clear cell renal carcinoma


subject: UMLS:C2346821

object_name: renal cell adenocarcinoma


subject: UMLS:C2346821

object_name: renal cell carcinoma


subject: CHEBI:15698

subject_name: Deoxycytidine


subject: CHEBI:15698


subject: CHEBI:15698


subject: CHEBI:15698


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: diffuse large B-cell lymphoma


subject: CHEBI:73604

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: CHEBI:73604

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: CHEBI:3395

subject_name: carbidopa

object_name: Depressed mood


subject: CHEBI:3395

object_name: Cancer patients and suicide and depression


subject: CHEBI:3395

object_name: Depressed - symptom


subject: CHEBI:3395

object_name: Depression, CTCAE


subject: CHEBI:3395

object_name: Gait impairment


subject: CHEBI:3395

object_name: Cognitive impairment


subject: CHEBI:94430

subject_name: DL-Carbidopa


subject: CHEBI:94430


subject: CHEBI:94430


subject: CHEBI:94430


subject: CHEBI:94430


subject: CHEBI:94430


subject: CHEBI:39585

subject_name: Carbidopa


subject: CHEBI:39585


subject: CHEBI:39585


subject: CHEBI:39585


subject: CHEBI:39585


subject: CHEBI:39585


subject: CHEBI:15765

subject_name: Levodopa


subject: CHEBI:15765


subject: CHEBI:15765


subject: CHEBI:15765


subject: CHEBI:15765


subject: CHEBI:15765


subject: UNII:SE2KH7T06F

object_name: Refractory Malignant Solid Neoplasm


subject: UMLS:C4287766

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C4287766

object_name: HER2 positive breast carcinoma


subject: UMLS:C4287766


subject: DRUGBANK:DB14101

subject_name: Soy isoflavones

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEBI:50859

subject_name: Bexarotene

object_name: Alzheimer disease


subject: UNII:612K359T69

subject_name: ALVESPIMYCIN HYDROCHLORIDE

object_name: adult lymphoma


subject: UNII:612K359T69

object_name: lymphoma


subject: UNII:612K359T69

object_name: pediatric lymphoma


subject: UNII:612K359T69

object_name: unspecified adult solid tumor, protocol specific


subject: UNII:612K359T69

object_name: small intestine cancer


subject: UNII:612K359T69

object_name: small intestine carcinoma


subject: UMLS:C2698077

subject_name: Alvespimycin Hydrochloride


subject: UMLS:C2698077


subject: UMLS:C2698077


subject: UMLS:C2698077


subject: UMLS:C2698077


subject: UMLS:C2698077


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: pulmonary embolism


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: MESH:C552097

object_name: social phobia


subject: CHEBI:29235

object_name: cardiac arrest


subject: CHEBI:29235

object_name: Cardiac Arrest, CTCAE


subject: CHEBI:29235

object_name: Reperfusion Injury


subject: CHEBI:18276

subject_name: Hydrogen


subject: CHEBI:18276


subject: CHEBI:18276


subject: UMLS:C0885426

subject_name: Hydrogen, Homeopathic preparation


subject: UMLS:C0885426


subject: UMLS:C0885426


subject: CHEMBL.COMPOUND:CHEMBL4297766

subject_name: HYDROGEN


subject: CHEMBL.COMPOUND:CHEMBL4297766


subject: CHEMBL.COMPOUND:CHEMBL4297766


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: diabetic kidney disease


subject: PUBCHEM.COMPOUND:73151030

object_name: maturity-onset diabetes of the young type 1


subject: UNII:25E79B5CTM

subject_name: Denileukin diftitox


subject: UNII:25E79B5CTM


subject: UNII:25E79B5CTM


subject: UMLS:C0211023


subject: UMLS:C0211023


subject: UMLS:C0211023


subject: UMLS:C3642356

object_name: Innate Inflammatory Response


subject: UMLS:C3642356

object_name: Atopic rhinitis


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: asthma


subject: CHEBI:26710


subject: CHEBI:26710


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: arteriosclerosis disorder


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: atherosclerosis


subject: DRUGBANK:DB16615

subject_name: Krill oil


subject: DRUGBANK:DB16615


subject: PUBCHEM.COMPOUND:75038


subject: PUBCHEM.COMPOUND:75038


subject: CHEBI:44245

subject_name: Menaquinone 7


subject: CHEBI:44245


subject: PUBCHEM.COMPOUND:66586232

object_name: Sepsis


subject: PUBCHEM.COMPOUND:66586232

object_name: Sepsis, CTCAE


subject: CHEBI:3614

subject_name: Chlorhexidine


subject: CHEBI:3614


subject: UMLS:C4287682

subject_name: c-Met Inhibitor HS-10241

object_name: Solid Neoplasm


subject: UMLS:C4287682

object_name: childhood neoplasm


subject: UMLS:C4287682

object_name: neoplastic syndrome


subject: UMLS:C4287682

object_name: cancer or benign tumor


subject: UMLS:C4287682

object_name: neoplasm


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: cocaine dependence


subject: UNII:2946IE3VYD

object_name: Plasma cell myeloma refractory


subject: UNII:2946IE3VYD

object_name: Plasma cell myeloma recurrent


subject: MESH:D016827

subject_name: CD8 Antigens


subject: MESH:D016827


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: UNII:3S182ET3UA

subject_name: TINZAPARIN SODIUM

object_name: Blood Clot


subject: UNII:3S182ET3UA

object_name: thrombosis


subject: UNII:3S182ET3UA

object_name: Thrombosis of blood vessel


subject: UNII:3S182ET3UA

object_name: thrombophilia due to thrombin defect


subject: UNII:3S182ET3UA

object_name: Venous thrombosis after immobility


subject: UNII:3S182ET3UA

object_name: Thromboembolism


subject: UNII:PUE0TO3XDR

subject_name: Dalteparin


subject: DRUGBANK:DB14764

subject_name: Dengue tetravalent vaccine, live

object_name: dengue disease


subject: UNII:513P80B4YJ

subject_name: Avapritinib

object_name: core binding factor acute myeloid leukemia


subject: UNII:513P80B4YJ

object_name: C-kit gene mutation


subject: UNII:513P80B4YJ

object_name: Refractory acute myeloid leukemia


subject: UNII:513P80B4YJ

object_name: Recurrence


subject: UNII:513P80B4YJ

object_name: childhood acute myeloid leukemia


subject: UMLS:C1618891

subject_name: Injection, azacitidine, 1 mg administered


subject: UMLS:C1618891


subject: UMLS:C1618891


subject: UMLS:C1618891


subject: UMLS:C1618891


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:2038


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: UMLS:C1738018

subject_name: INJECTION, DECITABINE, 1 MG ADMINISTERED


subject: UMLS:C1738018


subject: UMLS:C1738018


subject: UMLS:C1738018


subject: UMLS:C1738018


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: CHEBI:42068

subject_name: Idarubicin


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:42068


subject: MESH:C510903

subject_name: fluarix

object_name: HIV infection


subject: MESH:C510903

object_name: AIDS


subject: UMLS:C0071315

subject_name: Pneumovax


subject: UMLS:C0071315


subject: UNII:82MI0GT75Z

object_name: AIDS dementia


subject: UNII:82MI0GT75Z


subject: UNII:82MI0GT75Z

object_name: HIV Encephalopathy


subject: MESH:C526315


subject: MESH:C526315


subject: MESH:C526315


subject: UMLS:C5446895

subject_name: Anti-CTLA-4 Monoclonal Antibody IBI310

object_name: nasopharyngeal carcinoma


subject: UMLS:C5446895

object_name: Niemann-Pick disease type C


subject: UMLS:C5446895

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: GTOPDB:12990

subject_name: sintilimab


subject: GTOPDB:12990


subject: GTOPDB:12990


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: UMLS:C4329335

subject_name: IBI 308


subject: UMLS:C4329335


subject: UMLS:C4329335


subject: UNII:E1M30YOE59

subject_name: Simotaxel

object_name: neoplasm


subject: MESH:C540519

subject_name: PolyGlycoplex

object_name: Post-prandial blood sugar result


subject: CHEBI:17345


subject: CHEBI:61695

subject_name: L-prolylglycine


subject: CHEBI:64961


subject: CHEBI:14336

subject_name: glycerol 1-phosphate


subject: CHEBI:64956


subject: CHEBI:64716


subject: CHEBI:17334

subject_name: penicillin


subject: CHEBI:16997

subject_name: Propylene glycol


subject: CHEBI:10607

subject_name: Propyl Gallate


subject: CHEBI:15552

subject_name: Epoprostenol


subject: UNII:16VY3TM7ZO

subject_name: Antineoplaston A10

object_name: brain glioblastoma


subject: UMLS:C4721487

subject_name: ATENGENAL


subject: UMLS:C4721495

subject_name: Astugenal


subject: CHEBI:119915

subject_name: Fentanyl

object_name: ventricular tachycardia


subject: CHEBI:119915

object_name: Ventricular Tachycardia, CTCAE 3.0


subject: CHEBI:119915

object_name: continuous electrocardiogram ventricular tachycardia


subject: CHEBI:119915

object_name: Ventricular Tachycardia by ECG Finding


subject: CHEBI:119915

object_name: Ventricular Tachycardia, CTCAE 5.0


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:44915


subject: CHEBI:44915


subject: CHEBI:44915


subject: CHEBI:44915


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:9130


subject: CHEBI:9130


subject: CHEBI:9130


subject: CHEBI:9130


subject: UMLS:C0042553

subject_name: Versed


subject: UMLS:C0042553


subject: UMLS:C0042553


subject: UMLS:C0042553


subject: UMLS:C0042553


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:6931


subject: CHEBI:6931


subject: CHEBI:6931


subject: CHEBI:6931


subject: CHEBI:30762

subject_name: salicylate

object_name: seborrheic dermatitis


subject: CHEBI:30762

object_name: outcomes general quality of life


subject: CHEBI:30762

object_name: Perceived quality of life


subject: CHEBI:30762

object_name: Good quality of life


subject: CHEBI:30762

object_name: Greasy skin due to excessive secretion of sebum


subject: CHEBI:9008

subject_name: salicylurate


subject: CHEBI:9008


subject: CHEBI:9008


subject: CHEBI:9008


subject: CHEBI:9008


subject: CHEBI:16914

subject_name: Salicylic acid


subject: CHEBI:16914


subject: CHEBI:16914


subject: CHEBI:16914


subject: CHEBI:16914


subject: CHEBI:31398

subject_name: ciclopirox olamine


subject: CHEBI:31398


subject: CHEBI:31398


subject: CHEBI:31398


subject: CHEBI:31398


subject: CHEBI:453011

subject_name: Ciclopirox


subject: CHEBI:453011


subject: CHEBI:453011


subject: CHEBI:453011


subject: CHEBI:453011


subject: CHEBI:114785

subject_name: Erlotinib

object_name: Adult Grade III Meningioma


subject: CHEBI:114785

object_name: Adult Grade I Meningioma


subject: CHEBI:114785

object_name: Adult Grade II Meningioma


subject: CHEBI:114785

object_name: Recurrent Adult Brain Neoplasm


subject: CHEBI:114785

object_name: Adult Giant Cell Glioblastoma


subject: CHEBI:114785

object_name: Adult Anaplastic Oligodendroglioma


subject: CHEBI:114785

object_name: Adult Gliosarcoma


subject: CHEBI:114785

object_name: adult glioblastoma


subject: CHEBI:114785

object_name: Adult Anaplastic Astrocytoma


subject: CHEBI:84094

subject_name: testosterone sulfate

object_name: hypoactive sexual desire disorder


subject: UMLS:C4721537

subject_name: Therapeutic Testosterone


subject: CHEBI:17347

subject_name: Testosterone


subject: UNII:BN93L2NT5I

object_name: psoriasis


subject: UNII:BN93L2NT5I

object_name: atopic eczema


subject: CHEMBL.COMPOUND:CHEMBL4297709


subject: CHEMBL.COMPOUND:CHEMBL4297709


subject: CHEBI:31547

subject_name: Eplerenone

object_name: Primary hyperaldosteronism due to adrenal adenoma


subject: UNII:1Y26ZZ0OTM

subject_name: Magnesium-l-threonate

object_name: attention deficit hyperactivity disorder, inattentive type


subject: UNII:1Y26ZZ0OTM


subject: UMLS:C4307549

subject_name: L-threonic acid magnesium salt


subject: UMLS:C4307549


subject: PUBCHEM.COMPOUND:9838675

subject_name: ARTEMISININ


subject: MESH:D037621

subject_name: Artemisinins


subject: CHEBI:230430

subject_name: Ulinastatin

object_name: ulcerative oral mucositis due to radiation


subject: UNII:OR3S9IF86U

subject_name: urinastatin


subject: CHEMBL.COMPOUND:CHEMBL2108163

subject_name: ULINASTATIN


subject: UMLS:C0077906


subject: CHEBI:58097

object_name: Neutrophil extracellular trap formation


subject: CHEBI:58097

object_name: liver carcinoma


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: UMLS:C0242937

subject_name: Analgesics, Non-Narcotic

object_name: no feeling or sensation of skin


subject: UMLS:C0242937

object_name: Sensory Loss


subject: UMLS:C0242937


subject: UMLS:C0242937


subject: CHEBI:49900

subject_name: Arsenous acid

object_name: skin basal cell carcinoma


subject: CHEBI:49900

object_name: Recurrent Skin Carcinoma


subject: PUBCHEM.COMPOUND:518740

subject_name: Arsenic trioxide


subject: PUBCHEM.COMPOUND:518740


subject: CHEBI:30621

subject_name: diarsenic trioxide


subject: CHEBI:30621


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: UNII:6K6L7E3F1L

subject_name: Gefapixant

object_name: interstitial lung disease 1


subject: UNII:6K6L7E3F1L

object_name: interstitial lung disease 2


subject: UNII:6K6L7E3F1L

object_name: Cough


subject: UNII:6K6L7E3F1L

object_name: Cough, CTCAE


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel

object_name: breast neoplasm


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: diabetic retinopathy


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Genomic Instability


subject: CHEBI:28870

object_name: lung cancer


subject: CHEBI:28870

object_name: lung neoplasm


subject: CHEBI:28870

object_name: lung carcinoma


subject: CHEBI:6067

subject_name: Isotretinoin


subject: CHEBI:6067


subject: CHEBI:6067


subject: UNII:43K1W2T1M6

subject_name: Interferon alfa-2b


subject: UNII:43K1W2T1M6


subject: UNII:43K1W2T1M6


subject: UMLS:C1610033

subject_name: Interferon Alpha, Human


subject: UMLS:C1610033


subject: UMLS:C1610033


subject: PR:000024938

subject_name: interferon alpha


subject: PR:000024938


subject: PR:000024938


subject: UMLS:C2825023

subject_name: Interferon alpha [EPC]


subject: UMLS:C2825023


subject: UMLS:C2825023


subject: CHEBI:8499

subject_name: Propranolol

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:12043008

subject_name: Stribild

object_name: AIDS


subject: CHEBI:63717

subject_name: Tenofovir disoproxil


subject: CHEBI:31684

subject_name: Ibudilast

object_name: methamphetamine dependence


subject: CHEBI:31684

object_name: HIV infection


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: primary focal segmental glomerulosclerosis


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:94805

subject_name: Ataluren

object_name: cystic fibrosis


subject: CHEBI:6931

subject_name: Midazolam

object_name: Suicidal ideation


subject: CHEBI:6931

object_name: Suicidal Ideation, CTCAE


subject: CHEBI:6931

object_name: endogenous depression


subject: CHEBI:6931

object_name: major depressive disorder


subject: CHEBI:5000

subject_name: Fenfluramine

object_name: developmental and epileptic encephalopathy


subject: CHEBI:5000

object_name: West syndrome


subject: CHEBI:5000

object_name: Infantile Spasm


subject: DRUGBANK:DB16981

object_name: Angelman syndrome


subject: CHEBI:6503

subject_name: LISINOPRIL

object_name: hyperparathyroidism


subject: CHEBI:6503

object_name: Hyperparathyroidism, CTCAE


subject: CHEBI:43755

subject_name: Lisinopril


subject: CHEBI:43755


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: rectal carcinoma


subject: UNII:PQX0D8J21J

object_name: rectal cancer


subject: UNII:PQX0D8J21J

object_name: Childhood Rectal Carcinoma


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: CHEBI:8378

subject_name: Prednisolone

object_name: ankylosing spondylitis


subject: CHEBI:50847

subject_name: immunological adjuvant

object_name: Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site


subject: CHEBI:94688

subject_name: Acipimox

object_name: type 1 diabetes mellitus


subject: CHEBI:3181

subject_name: Bromocriptine

object_name: diabetic macular edema


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin

object_name: neoplasm


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: CHEBI:63605

subject_name: Ixabepilone


subject: UNII:FKO8A7AD54

subject_name: Bocidelpar

object_name: Hepatic impairment


subject: UNII:AHU547PI9H

subject_name: Ferric derisomaltose

object_name: Anaemia postoperative


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: lung cancer


subject: CHEBI:4466

object_name: lung neoplasm


subject: CHEBI:4466

object_name: lung carcinoma


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:8WE94VAO6U

subject_name: chiglitazar

object_name: type 2 diabetes mellitus


subject: UMLS:C4529398

subject_name: Multi Vitamin+

object_name: pervasive developmental disorder


subject: UMLS:C4529398

object_name: autism


subject: UMLS:C0556112

subject_name: Mineral supplements


subject: UMLS:C0556112


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: stage, gastric cancer


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: UMLS:C3827032

subject_name: Catequentinib Hydrochloride

object_name: Small cell lung cancer recurrent


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:31536

subject_name: Emtricitabine

object_name: AIDS


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: Diabetic Neuralgia


subject: CHEBI:64356

subject_name: Pregabalin


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: B-cell chronic lymphocytic leukemia


subject: UNII:2S9ZZM9Q9V

object_name: Chronic lymphocytic leukaemia refractory


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: UNII:D59N834676

subject_name: EZATIOSTAT HYDROCHLORIDE

object_name: severe congenital neutropenia


subject: UMLS:C1612297

subject_name: Telintra


subject: UNII:4FR53SIF3A

subject_name: Blinatumomab

object_name: acute lymphoblastic leukemia


subject: UNII:4FR53SIF3A

object_name: lymphoid leukemia


subject: UNII:4FR53SIF3A

object_name: Philadelphia Chromosome Positive


subject: UNII:KV1M7Q3CBP


subject: UNII:KV1M7Q3CBP


subject: UNII:KV1M7Q3CBP


subject: CHEBI:119915

subject_name: Fentanyl

object_name: ST-elevation myocardial infarction


subject: CHEBI:119915

object_name: ST Elevation Myocardial Infarction


subject: CHEBI:46195

subject_name: Acetaminophen


subject: CHEBI:46195


subject: CHEBI:74947

subject_name: Thalidomide

object_name: inflammatory bowel disease 1


subject: CHEBI:74947

object_name: Crohn disease


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Schizophrenia Spectrum and Other Psychotic Disorders


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UNII:914032762Y

subject_name: PENTOSAN POLYSULFATE SODIUM

object_name: diarrhea


subject: UNII:914032762Y

object_name: rectal discharge diarrhea (physical finding)


subject: UNII:914032762Y

object_name: Diarrhea, CTCAE


subject: UNII:914032762Y

object_name: Radiation enteritis of intestine


subject: CHEBI:184555

subject_name: Xylan Sulfate


subject: CHEBI:184555


subject: CHEBI:184555


subject: CHEBI:184555


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Metastatic non-small cell lung cancer


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: UMLS:C4726586

subject_name: ADC DS-1062a


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:63724


subject: PUBCHEM.COMPOUND:6012

subject_name: Durandro

object_name: Mechanical ventilation complication


subject: PUBCHEM.COMPOUND:6012

object_name: Intensive care unit acquired weakness


subject: PUBCHEM.COMPOUND:6012

object_name: Mobility Limitation


subject: PUBCHEM.COMPOUND:6012

object_name: Paresis


subject: PUBCHEM.COMPOUND:6012

object_name: Muscle weakness


subject: PUBCHEM.COMPOUND:6012

object_name: Weaning failure


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:17347


subject: CHEBI:17347


subject: CHEBI:17347


subject: CHEBI:17347


subject: CHEBI:17347


subject: UNII:B5TAN0L720

subject_name: Picoplatin

object_name: colorectal cancer


subject: UNII:B5TAN0L720

object_name: colorectal carcinoma


subject: UNII:B5TAN0L720

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)